Driehaus Capital Management
Overview
Driehaus Capital Management is a privately-held investment management firm that specializes in active growth equity, emerging markets, and alternative investment strategies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MBX Biosciences | Aug 2024 | Series C | - |
| Jade Biosciences, Inc. | Apr 2025 | M&A | Co-investor |
| Septerna | Jul 2023 | Series B | Co-investor |
| Maze Therapeutics | Sep 2025 | Private Placement | Co-investor |
| Pulmonx | May 2019 | Series G | Co-investor |
For institutional investors. Book with your work email.
Key People
David Mouser
Portfolio Manager
Howie Schwab
Portfolio Manager
Jeff James
Portfolio Manager
Richard Thies
Portfolio Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Driehaus Capital Management based?
Driehaus Capital Management is headquartered in Chicago, Illinois, United States.
When was Driehaus Capital Management founded?
Driehaus Capital Management was founded in 1982.
How many portfolio companies does Driehaus Capital Management have?
Driehaus Capital Management has 17 portfolio companies in Caplight's dataset.
What are some companies in Driehaus Capital Management's portfolio?
Portfolio companies visible on Caplight include MBX Biosciences, Jade Biosciences, Inc., Septerna, Maze Therapeutics, Pulmonx.
What was Driehaus Capital Management's most recent investment shown here?
Driehaus Capital Management's most recent investment in this portfolio sample was in Maze Therapeutics in 2025.
What sectors does Driehaus Capital Management focus on?
Driehaus Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Driehaus Capital Management focus on?
Driehaus Capital Management typically invests at the Mid stage.
What is Driehaus Capital Management's AUM?
Driehaus Capital Management's assets under management are estimated between $10.0B and $100.0B.